ISRCTN58831878Completed未知
A randomised trial of high dose therapy and autologous bone marrow transplantation versus continuing conventional combination chemotherapy for adults with lymphoblastic lymphoma
Cancer Research UK (CRUK) (UK)0 sites119 target enrollmentStarted: July 1, 2001Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 119
Study Overview
Brief Summary
2001 results in: ncbi.nlm.nih.gov/pubmed/11387366 (added 28/11/2019)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Histologically documented lymphoblastic lymphoma
- •2. No prior chemotherapy or radiotherapy, except chemotherapy given for immediate relief of symptoms at presentation
- •3. Age 15 or over
- •4. All stages
- •5. No circulating blasts
- •6. Normal values for renal and hepatic function, unless directly attributable to lymphoma
- •7. Normal cardiac function
- •8. No evidence of Human Immunodeficiency Virus (HIV) infection
Exclusion Criteria
- •Patients will be excluded if they have HLA-identical siblings who are undergoing allogenic bone marrow transplantation. These patients should be registered with the trials office but will not be randomised.
Investigators
Similar Trials
Completed
Not Applicable
A randomised controlled trial of high-dose immunosuppression in paraquat poisoningParaquat poisoningInjury, Occupational Diseases, PoisoningISRCTN85372848South Asian Clinical Toxicology Research Collaboration (SACTRC) (Sri Lanka)299
Completed
Phase 4
Comparing different dosing regimens of Avastin® in the treatment of wet age-related macular degeneratioISRCTN95654194ottingham University Hospitals NHS Trust (UK)812
Completed
Not Applicable
A randomised trial to evaluate early high dose therapy and autologous bone marrow transplantation as part of planned initial therapy for poor risk intermediate/high grade non-Hodgkin's lymphomaymphoma (non-Hodgkin's)Lymphoma (non-Hodgkin's)CancerISRCTN97344827Cancer Research UK (CRUK) (UK)
Completed
Not Applicable
Multicentre randomised trial of High dose versus Low dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation following surgery for differentiated thyroid cancerThyroid cancerCancerISRCTN56078540niversity College London (UK)468
Unknown
Phase 3
Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain MetastasesNSCLCNCT04870190Shanghai Chest Hospital232